| 注册
首页|期刊导航|临床肝胆病杂志|中药有效成分及其复方防治非酒精性脂肪性肝病的现状与展望

中药有效成分及其复方防治非酒精性脂肪性肝病的现状与展望

潘雨晴 毛傲洁 于楚楚 胡义扬

临床肝胆病杂志2024,Vol.40Issue(10):1933-1941,9.
临床肝胆病杂志2024,Vol.40Issue(10):1933-1941,9.DOI:10.12449/JCH241002

中药有效成分及其复方防治非酒精性脂肪性肝病的现状与展望

Active components of traditional Chinese medicine and their compound prescriptions in prevention and treatment of nonalcoholic fatty liver disease:Current status and prospects

潘雨晴 1毛傲洁 1于楚楚 1胡义扬1

作者信息

  • 1. 上海中医药大学附属曙光医院,上海中医药大学肝病研究所,上海中医药大学教育部肝肾疾病重点实验室,上海市中医临床重点实验室,上海 201203
  • 折叠

摘要

Abstract

Nonalcoholic fatty liver disease(NAFLD)is currently a chronic liver disease with the highest prevalence rate in the world,with complex pathogeneses and limited clinical treatment methods.Over the past 20 years,the discovery of active components for NAFLD treatment from traditional Chinese medicine and compound prescriptions of the components that can exert a multi-target effect has been one of the research hotspots.Based on the chemical components of traditional Chinese medicine,this article elaborates on the active components with a promising future in the treatment of NAFLD,including flavonoids,phenols,terpenoids,alkaloids,and saponins,as well as the compound prescriptions of active components with a synergistic effect,in order to provide new ideas for the strategies of pharmacotherapy for NAFLD.

关键词

非酒精性脂肪性肝病/中药/复方配伍

Key words

Non-alcoholic Fatty Liver Disease/Traditional Chinese Drugs/Concerted Application of Prescription

引用本文复制引用

潘雨晴,毛傲洁,于楚楚,胡义扬..中药有效成分及其复方防治非酒精性脂肪性肝病的现状与展望[J].临床肝胆病杂志,2024,40(10):1933-1941,9.

基金项目

国家自然科学基金面上项目(82174186) General Project of National Natural Science Foundation of China(82174186) (82174186)

临床肝胆病杂志

OA北大核心CSTPCD

1001-5256

访问量0
|
下载量0
段落导航相关论文